+
Covestro Begins Local Medical-Grade TPU Production in Taiwan
ECONOMY & POLICY

Covestro Begins Local Medical-Grade TPU Production in Taiwan

Covestro has launched localised production of medical-grade Thermoplastic Polyurethane (TPU) at its Changhua site in Taiwan, marking its first such facility in the Asia Pacific region. The site, now qualified for medical-grade TPU manufacturing, will produce Desmopan® Rx grades, enabling faster and more secure regional supply for high-performance medical applications.

This is Covestro’s second global site after New Martinsville, North America, to manufacture medical-grade TPU. The move reflects rising demand driven by improved healthcare standards and an ageing global population.

Meeting Global Standards, Serving Regional Needs

Manufactured in line with Good Manufacturing Practice (GMP) guidelines, Desmopan® Rx grades meet international medical standards including ISO 10993 and China’s YY/T 1557, ensuring biocompatibility and minimised contamination risks. Free from added plasticisers, the TPU grades offer low extractables and are compatible with multiple sterilisation methods.

Dr Frank Yang, Head of Asia-Pacific Innovation TPU at Covestro, stated: “Our Desmopan® Rx grades meet established medical industry standards. This production shift ensures product safety, compliance, and timely delivery for regulated Asian markets.”

Designed for Advanced Medical Use

Desmopan® Rx TPUs are tailored for a wide range of medical devices, including tubing, catheters, connectors, housings, endoscopes, and wearable devices. Their use spans surgical procedures, drug delivery, dialysis, wound care, and more.

The material’s benefits include:

  • Biocompatibility for patient-contact use
  • High clarity for medical observation
  • Kink resistance for uninterrupted fluid flow
  • Excellent chemical and abrasion resistance
  • Superior flexibility and dimensional stability

Additionally, Desmopan® Rx is suitable for melt-blown medical nonwovens used in drapes, gowns, sterile packaging, and PPE, offering strong performance while complying with medical waste regulations.

Strengthening Regional Infrastructure

The Changhua facility complements Covestro’s Zhuhai production base and its new application development centre in Guangzhou, enhancing local innovation and delivery capabilities. Kevin Ho, Head of Sales and Market Development TPU Asia Pacific, noted, “With Changhua online, we can now shorten lead times and improve supply reliability for the region.”

Covestro is showcasing the Desmopan® Rx range at Booth N5E24 during CPHI & PMEC China, running through 26 June at the Shanghai New International Expo Center.

Covestro has launched localised production of medical-grade Thermoplastic Polyurethane (TPU) at its Changhua site in Taiwan, marking its first such facility in the Asia Pacific region. The site, now qualified for medical-grade TPU manufacturing, will produce Desmopan® Rx grades, enabling faster and more secure regional supply for high-performance medical applications.This is Covestro’s second global site after New Martinsville, North America, to manufacture medical-grade TPU. The move reflects rising demand driven by improved healthcare standards and an ageing global population.Meeting Global Standards, Serving Regional NeedsManufactured in line with Good Manufacturing Practice (GMP) guidelines, Desmopan® Rx grades meet international medical standards including ISO 10993 and China’s YY/T 1557, ensuring biocompatibility and minimised contamination risks. Free from added plasticisers, the TPU grades offer low extractables and are compatible with multiple sterilisation methods.Dr Frank Yang, Head of Asia-Pacific Innovation TPU at Covestro, stated: “Our Desmopan® Rx grades meet established medical industry standards. This production shift ensures product safety, compliance, and timely delivery for regulated Asian markets.”Designed for Advanced Medical UseDesmopan® Rx TPUs are tailored for a wide range of medical devices, including tubing, catheters, connectors, housings, endoscopes, and wearable devices. Their use spans surgical procedures, drug delivery, dialysis, wound care, and more.The material’s benefits include:Biocompatibility for patient-contact useHigh clarity for medical observationKink resistance for uninterrupted fluid flowExcellent chemical and abrasion resistanceSuperior flexibility and dimensional stabilityAdditionally, Desmopan® Rx is suitable for melt-blown medical nonwovens used in drapes, gowns, sterile packaging, and PPE, offering strong performance while complying with medical waste regulations.Strengthening Regional InfrastructureThe Changhua facility complements Covestro’s Zhuhai production base and its new application development centre in Guangzhou, enhancing local innovation and delivery capabilities. Kevin Ho, Head of Sales and Market Development TPU Asia Pacific, noted, “With Changhua online, we can now shorten lead times and improve supply reliability for the region.”Covestro is showcasing the Desmopan® Rx range at Booth N5E24 during CPHI & PMEC China, running through 26 June at the Shanghai New International Expo Center.

Next Story
Infrastructure Urban

Naidu Seeks Rs 563 Crore For AP Sports Infrastructure

Andhra Pradesh Chief Minister N Chandrababu Naidu has sought Rs 563 crore from the Centre to boost sports infrastructure in the state, including Rs 538 crore for stadium development and Rs 25 crore to host the Khelo India Martial Arts Games 2025. Naidu made the request during a meeting with Union Youth Services and Sports Minister Mansukh Mandaviya in New Delhi on Wednesday.The CM urged early completion of Khelo India infrastructure projects in Tirupati, Rajahmundry, Kakinada, and Narasaraopeta, and called for an international-standard badminton training centre and a national aquatic sports hu..

Next Story
Infrastructure Transport

Tough Bidding Norms Slow NHAI Road Project Awards

Stringent bidding rules imposed by the Ministry of Road Transport & Highways (MoRTH) have led to a slowdown in project awards by the National Highways Authority of India (NHAI), despite a robust Rs 3.5 trillion pipeline. According to an HDFC Securities report, the shift to more cautious developer models now favours firms with strong balance sheets, as tighter qualification norms limit aggressive bidders.The revised norms mandate additional performance security, targeting the exclusion of players that previously submitted low bids—often 25 to 40 per cent below NHAI cost estimates—raisin..

Next Story
Infrastructure Transport

Mumbai Gets Coastal Nod for Next Promenade Phase

As Mumbai prepares to open two major sections of its expansive seafront promenade this week, the city’s civic authority has secured a key coastal clearance to advance further construction. The Maharashtra Coastal Zone Management Authority (MCZMA) has approved the commencement of work on the segment between Haji Ali and Baroda Palace, with tendering expected soon after project cost assessments.The promenade, stretching 7.5 km in length and 20 metres wide, is being designed as a flagship open space for walkers, joggers, and cyclists. Two critical stretches—2.75 km from Tata Garden to Haji Al..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?